Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Scilex Holding (SCLX) Cash & Equivalents (2020 - 2025)

Scilex Holding has reported Cash & Equivalents over the past 6 years, most recently at $230.1 million for Q4 2025.

  • On a quarterly basis, Cash & Equivalents rose 6933.62% to $230.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $230.1 million, a 6933.62% increase, with the full-year FY2025 number at $230.1 million, up 6933.62% from a year prior.
  • Cash & Equivalents reached $230.1 million in Q4 2025 per SCLX's latest filing, up from $900000.0 in the prior quarter.
  • The five-year high for Cash & Equivalents was $230.1 million in Q4 2025, with the low at $34961.0 in Q3 2022.
  • The 5-year median for Cash & Equivalents is $2.1 million (2022), against an average of $15.3 million.
  • Peak YoY movement for Cash & Equivalents: surged 14117.82% in 2021, then crashed 94.88% in 2024.
  • Tracing SCLX's Cash & Equivalents over 5 years: stood at $4.3 million in 2021, then plummeted by 49.65% to $2.2 million in 2022, then surged by 79.53% to $3.9 million in 2023, then dropped by 16.55% to $3.3 million in 2024, then surged by 6933.62% to $230.1 million in 2025.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $230.1 million, $900000.0, and $4.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.